162 related articles for article (PubMed ID: 35709641)
1. Combined noradrenergic plus antimuscarinic agents for obstructive sleep apnea - A systematic review and meta-analysis of randomized controlled trials.
Zha S; Yang H; Yue F; Zhang Q; Hu K
Sleep Med Rev; 2022 Aug; 64():101649. PubMed ID: 35709641
[TBL] [Abstract][Full Text] [Related]
2. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.
Aishah A; Lim R; Sands SA; Taranto-Montemurro L; Wellman A; Carberry JC; Eckert DJ
J Appl Physiol (1985); 2021 May; 130(5):1373-1382. PubMed ID: 33734828
[TBL] [Abstract][Full Text] [Related]
3. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial.
Lim R; Messineo L; Grunstein RR; Carberry JC; Eckert DJ
J Physiol; 2021 Sep; 599(17):4183-4195. PubMed ID: 34174090
[TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for obstructive sleep apnea - A systematic review and meta-analysis of randomized controlled trials.
Lee YC; Lu CT; Chuang LP; Lee LA; Fang TJ; Cheng WN; Li HY
Sleep Med Rev; 2023 Aug; 70():101809. PubMed ID: 37423095
[TBL] [Abstract][Full Text] [Related]
5. A single dose of noradrenergic/serotonergic reuptake inhibitors combined with an antimuscarinic does not improve obstructive sleep apnoea severity.
Thomson LDJ; Landry SA; Joosten SA; Mann DL; Wong AM; Cheung T; Adam M; Beatty CJ; Hamilton GS; Edwards BA
Physiol Rep; 2022 Aug; 10(16):e15440. PubMed ID: 36029192
[TBL] [Abstract][Full Text] [Related]
6. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.
Aishah A; Loffler KA; Toson B; Mukherjee S; Adams RJ; Altree TJ; Ainge-Allen HW; Yee BJ; Grunstein RR; Carberry JC; Eckert DJ
Ann Am Thorac Soc; 2023 Apr; 20(4):584-595. PubMed ID: 36538809
[No Abstract] [Full Text] [Related]
7. Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits.
Taranto-Montemurro L; Messineo L; Azarbarzin A; Vena D; Hess LB; Calianese NA; White DP; Wellman A; Sands SA
Chest; 2020 Jun; 157(6):1626-1636. PubMed ID: 32006590
[TBL] [Abstract][Full Text] [Related]
8. The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.
Altree TJ; Aishah A; Loffler KA; Grunstein RR; Eckert DJ
J Clin Sleep Med; 2023 Jan; 19(1):85-96. PubMed ID: 36004739
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory medications for obstructive sleep apnoea in children.
Kuhle S; Hoffmann DU; Mitra S; Urschitz MS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD007074. PubMed ID: 31978261
[TBL] [Abstract][Full Text] [Related]
10. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.
Taranto-Montemurro L; Messineo L; Sands SA; Azarbarzin A; Marques M; Edwards BA; Eckert DJ; White DP; Wellman A
Am J Respir Crit Care Med; 2019 May; 199(10):1267-1276. PubMed ID: 30395486
[No Abstract] [Full Text] [Related]
11. The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial.
Schweitzer PK; Taranto-Montemurro L; Ojile JM; Thein SG; Drake CL; Rosenberg R; Corser B; Abaluck B; Sangal RB; Maynard J
Am J Respir Crit Care Med; 2023 Dec; 208(12):1316-1327. PubMed ID: 37812772
[No Abstract] [Full Text] [Related]
12. Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway.
Corser B; Eves E; Warren-McCormick J; Rucosky G
J Clin Sleep Med; 2023 Jun; 19(6):1035-1042. PubMed ID: 36734173
[TBL] [Abstract][Full Text] [Related]
13. Effect of norepinephrine reuptake inhibitors combined antimuscarinic agents versus monotherapy for OSA: a systematic review and meta-analysis.
Wang J; Ye Y; Shang Z; Zheng Q; Zhang S; Li L; Liu W
J Clin Sleep Med; 2024 Mar; ():. PubMed ID: 38494994
[TBL] [Abstract][Full Text] [Related]
14. Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA.
Rosenberg R; Abaluck B; Thein S
J Clin Sleep Med; 2022 Dec; 18(12):2837-2844. PubMed ID: 35975547
[TBL] [Abstract][Full Text] [Related]
15. Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility.
Messineo L; Taranto-Montemurro L; Calianese N; Gell LK; Azarbarzin A; Labarca G; Vena D; Yang HC; Wang TY; Wellman A; Sands SA
Respirology; 2022 Nov; 27(11):975-982. PubMed ID: 35811347
[TBL] [Abstract][Full Text] [Related]
16. Impact of cold and flu medication on obstructive sleep apnoea and its underlying traits: A pilot randomized controlled trial.
Taranto-Montemurro L; Sands S; Azarbarzin A; Calianese N; Vena D; Hess L; Kim SW; White DP; Wellman A
Respirology; 2021 May; 26(5):485-492. PubMed ID: 33491327
[TBL] [Abstract][Full Text] [Related]
17. The Combination of Supplemental Oxygen and a Hypnotic Markedly Improves Obstructive Sleep Apnea in Patients with a Mild to Moderate Upper Airway Collapsibility.
Edwards BA; Sands SA; Owens RL; Eckert DJ; Landry S; White DP; Malhotra A; Wellman A
Sleep; 2016 Nov; 39(11):1973-1983. PubMed ID: 27634790
[TBL] [Abstract][Full Text] [Related]
18. Comparison of positional therapy versus continuous positive airway pressure in patients with positional obstructive sleep apnea: a meta-analysis of randomized trials.
Ha SC; Hirai HW; Tsoi KK
Sleep Med Rev; 2014 Feb; 18(1):19-24. PubMed ID: 23831268
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of oxygen therapy for patients who do not respond to upper airway surgery for obstructive sleep apnea.
Joosten SA; Tan M; Wong AM; Landry SA; Leong P; Sands SA; Beatty C; Thomson L; Stonehouse J; Turton A; Hamilton GS; Edwards BA
J Clin Sleep Med; 2021 Mar; 17(3):445-452. PubMed ID: 33094725
[TBL] [Abstract][Full Text] [Related]
20. Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
Perger E; Taranto Montemurro L; Rosa D; Vicini S; Marconi M; Zanotti L; Meriggi P; Azarbarzin A; Sands SA; Wellman A; Lombardi C; Parati G
Chest; 2022 Jan; 161(1):237-247. PubMed ID: 34543665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
